Ekf Diagnostics Holding PLC Receives “Buy” Rating from Canaccord Genuity (EKF)
Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating reaffirmed by Canaccord Genuity in a research note issued on Tuesday. They currently have a GBX 48 ($0.81) target price on the stock. Canaccord Genuity’s target price would indicate a potential upside of 100.00% from the stock’s previous close.
Shares of Ekf Diagnostics Holding PLC (LON:EKF) traded up 4.08% on Tuesday, hitting GBX 25.50. The stock had a trading volume of 1,083,781 shares. Ekf Diagnostics Holding PLC has a one year low of GBX 23.60 and a one year high of GBX 43.00. The stock’s 50-day moving average is GBX 32.18 and its 200-day moving average is GBX 34.17.
A number of other analysts have also recently weighed in on EKF. Analysts at N+1 Singer reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Thursday, March 20th. They now have a GBX 41 ($0.69) price target on the stock. Separately, analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Wednesday, March 12th. They now have a GBX 41 ($0.69) price target on the stock.
EKF Diagnostics Holdings Plc designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.